The SOX17 phenotype in pulmonary arterial hypertension: lessons for pathobiology and clinical management

Eur Respir J. 2022 Dec 8;60(6):2201438. doi: 10.1183/13993003.01438-2022. Print 2022 Dec.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Familial Primary Pulmonary Hypertension
  • Humans
  • Pulmonary Arterial Hypertension* / therapy
  • SOXF Transcription Factors / genetics

Substances

  • SOX17 protein, human
  • SOXF Transcription Factors